newsfilter
← Latest News
GlobeNewswire·

Interpace Biosciences Announces Preliminary Full-year and Fourth Quarter 2024 Financial and Business Results

●Q4 and FY Test volume increase 21% and 17% year-over-year ●Q4 and FY Volume, Revenue, and Profitability at all-time record levels PARSIPPANY, NJ, Jan. 31, 2025 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc.